Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan G Schwartz

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Molecular and Cellular Cardiology|June 30, 2011
Coronary no reflowBryan G Schwartz, Robert A Kloner
The Journal of Invasive Cardiology|January 3, 2012
Impella-assisted balloon aortic valvuloplastyDaniel J Ludeman, Bryan G Schwartz, Steven Burstein
The American Journal of Medicine|November 2, 2010
Sporting events affect spectators' cardiovascular mortality: it is not just a gameJustin Leeka, Bryan G Schwartz, Robert A Kloner
The American Journal of Cardiology|October 13, 2018
Acute and Subacute Triggers of Cardiovascular EventsBryan G Schwartz, Robert A Kloner, Morteza Naghavi
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 28, 2013
Super Bowl outcome's association with cardiovascular deathBryan G Schwartz, Scott Andrew McDonald, Robert A Kloner
The American Journal of Cardiology|August 23, 2015
Relation of Total and Cardiovascular Death Rates to Climate System, Temperature, Barometric Pressure, and Respiratory InfectionBryan G Schwartz, Clifford Qualls, Robert A Kloner, et al.
Hospital Practice (1995)|October 5, 2010
When and why do heart attacks occur? Cardiovascular triggers and their potential roleBryan G Schwartz, Guy S Mayeda, Steven Burstein, et al.
The Journal of Invasive Cardiology|June 12, 2012
Treating peripheral arterial disease percutaneously with atherectomyBryan G Schwartz, Robert A Kloner, Steven Burstein, et al.
Journal of the American College of Cardiology|December 24, 2011
Cardiac uses of phosphodiesterase-5 inhibitorsBryan G Schwartz, Laurence A Levine, Gary Comstock, et al.
The American Journal of Medicine|February 16, 2013
Phosphodiesterase type 5 inhibitors improve endothelial function and may benefit cardiovascular conditionsBryan G Schwartz, Graham Jackson, Vera J Stecher, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Molecular and Cellular Cardiology|June 30, 2011
Coronary no reflowBryan G Schwartz, Robert A Kloner
The Journal of Invasive Cardiology|January 3, 2012
Impella-assisted balloon aortic valvuloplastyDaniel J Ludeman, Bryan G Schwartz, Steven Burstein
The American Journal of Medicine|November 2, 2010
Sporting events affect spectators' cardiovascular mortality: it is not just a gameJustin Leeka, Bryan G Schwartz, Robert A Kloner
The American Journal of Cardiology|October 13, 2018
Acute and Subacute Triggers of Cardiovascular EventsBryan G Schwartz, Robert A Kloner, Morteza Naghavi
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 28, 2013
Super Bowl outcome's association with cardiovascular deathBryan G Schwartz, Scott Andrew McDonald, Robert A Kloner
The American Journal of Cardiology|August 23, 2015
Relation of Total and Cardiovascular Death Rates to Climate System, Temperature, Barometric Pressure, and Respiratory InfectionBryan G Schwartz, Clifford Qualls, Robert A Kloner, et al.
Hospital Practice (1995)|October 5, 2010
When and why do heart attacks occur? Cardiovascular triggers and their potential roleBryan G Schwartz, Guy S Mayeda, Steven Burstein, et al.
The Journal of Invasive Cardiology|June 12, 2012
Treating peripheral arterial disease percutaneously with atherectomyBryan G Schwartz, Robert A Kloner, Steven Burstein, et al.
Journal of the American College of Cardiology|December 24, 2011
Cardiac uses of phosphodiesterase-5 inhibitorsBryan G Schwartz, Laurence A Levine, Gary Comstock, et al.
The American Journal of Medicine|February 16, 2013
Phosphodiesterase type 5 inhibitors improve endothelial function and may benefit cardiovascular conditionsBryan G Schwartz, Graham Jackson, Vera J Stecher, et al.
Pageof 2